丙酰辅酶A代谢降低促进代谢重编程并推动肝细胞癌发生
本研究探讨丙酰辅酶A(Pro-CoA)代谢在肝细胞癌(HCC)代谢重编程和肝癌发生中的作用。利用TCGA数据和HCC样本分析ALDH6A1介导的Pro-CoA代谢,通过靶向质谱检测代谢物,并在HCC细胞系、异种移植裸鼠模型和原发性肝癌小鼠模型中评估功能。结果显示ALDH6A1下调导致Pro-CoA及其衍生物丙酰左旋肉碱降低,与HCC密切相关;ALDH6A1介导的Pro-CoA代谢抑制HCC增殖并损害肝癌发生,其机制涉及抑制柠檬酸合酶活性、减少三羧酸循环通量、损害线粒体呼吸和膜电位、降低ATP产生,以及生成2-甲基柠檬酸模拟Pro-CoA的抑制作用。结论认为ALDH6A1介导的Pro-CoA代谢下降促进代谢重塑和肝癌发生,Pro-CoA、丙酰左旋肉碱和2-甲基柠檬酸可能作为HCC诊断和治疗的新的代谢生物标志物,Pro-CoA代谢可能为开发抗HCC新策略提供潜在靶点。
要点
- ALDH6A1下调导致Pro-CoA和丙酰左旋肉碱降低,与HCC紧密相关。
- ALDH6A1介导的Pro-CoA代谢在体外抑制HCC增殖,在小鼠中损害肝癌发生。
- Pro-CoA抑制柠檬酸合酶,减少TCA循环通量,损害线粒体呼吸和ATP产生。
核心结论
- ALDH6A1介导的Pro-CoA代谢下降促进代谢重塑并推动肝癌发生。
- Pro-CoA、丙酰左旋肉碱和2-甲基柠檬酸可能作为HCC诊断和治疗的新的代谢生物标志物。
- Pro-CoA代谢可能为开发抗HCC新策略提供潜在靶点。
研究设计与样本
- 使用TCGA数据和HCC样本分析ALDH6A1介导的Pro-CoA代谢及其与HCC的相关性。
- 通过靶向质谱检测多种代谢物。
- 在HCC细胞系、异种移植裸鼠模型和原发性肝癌小鼠模型中评估ALDH6A1生成的Pro-CoA的作用。
- 进行非靶向代谢组学和靶向能量代谢组学分析以及多种生化实验。
主要发现
- ALDH6A1下调导致Pro-CoA及其衍生物丙酰左旋肉碱降低,与HCC紧密相关。
- ALDH6A1介导的Pro-CoA代谢在体外抑制HCC增殖,在小鼠中损害肝癌发生。
- 醛脱氢酶活性对ALDH6A1该功能不可或缺,而Pro-CoA羧化酶通过消除Pro-CoA拮抗ALDH6A1功能。
- ALDH6A1生成的Pro-CoA抑制柠檬酸合酶活性,减少TCA循环通量,损害线粒体呼吸和膜电位,降低ATP产生。
- Pro-CoA代谢生成2-甲基柠檬酸,模拟Pro-CoA对柠檬酸合酶的抑制作用,抑制线粒体呼吸和HCC增殖。
临床怎么用
- 作者认为Pro-CoA、丙酰左旋肉碱和2-甲基柠檬酸可能作为HCC诊断和治疗的新的代谢生物标志物。
- 作者认为Pro-CoA代谢可能为开发抗HCC新策略提供潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Alterations of multiple metabolites characterize distinct features of metabolic reprograming in hepatocellular carcinoma (HCC). However, the role of most metabolites, including propionyl-CoA (Pro-CoA), in metabolic reprogramming and hepatocarcinogenesis remains elusive. In this study, we aimed to dissect how Pro-CoA metabolism affects these processes. METHODS: TCGA data and HCC samples were used to analyze ALDH6A1-mediated Pro-CoA metabolism and its correlation with HCC. Multiple metabolites were assayed by targeted mass spectrometry. The role of ALDH6A1-generated Pro-CoA in HCC was evaluated in HCC cell lines as well as xenograft nude mouse models and primary liver cancer mouse models. Non-targeted metabolomic and targeted energy metabolomic analyses, as well as multiple biochemical assays, were performed. RESULTS: Decreases in Pro-CoA and its derivative propionyl-L-carnitine due to ALDH6A1 downregulation were tightly associated with HCC. Functionally, ALDH6A1-mediated Pro-CoA metabolism suppressed HCC proliferation in vitro and impaired hepatocarcinogenesis in mice. The aldehyde dehydrogenase activity was indispensable for this function of ALDH6A1, while Pro-CoA carboxylases antagonized ALDH6A1 function by eliminating Pro-CoA. Mechanistically, ALDH6A1 caused a signature enrichment of central carbon metabolism in cancer and impaired energy metabolism: ALDH6A1-generated Pro-CoA suppressed citrate synthase activity, which subsequently reduced tricarboxylic acid cycle flux, impaired mitochondrial respiration and membrane potential, and decreased ATP production. Moreover, Pro-CoA metabolism generated 2-methylcitric acid, which mimicked the inhibitory effect of Pro-CoA on citrate synthase and dampened mitochondrial respiration and HCC proliferation. CONCLUSIONS: The decline of ALDH6A1-mediated Pro-CoA metabolism contributes to metabolic remodeling and facilitates hepatocarcinogenesis. Pro-CoA, propionyl-L-carnitine and 2-methylcitric acid may serve as novel metabolic biomarkers for the diagnosis and treatment of HCC. Pro-CoA metabolism may provide potential targets for development of novel strategies against HCC. IMPACT AND IMPLICATIONS: Our study presents new insights on the role of propionyl-CoA metabolism in metabolic reprogramming and hepatocarcinogenesis. This work has uncovered potential diagnostic and predictive biomarkers, which could be used by physicians to improve clinical practice and may also serve as targets for the development of therapeutic strategies against HCC.
引用
- Sun J, Ding J, Shen Q, et al. Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma. J Hepatol. 2022. PMID: 36462680. doi:10.1016/j.jhep.2022.11.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。